Instituto de Oftalmología Aplicada de Valladolid-ko ikertzaileekin lankidetzan egindako argitalpenak (41)

2024

  1. Clinical exome analysis and targeted gene repair of the c.1354dupT variant in iPSC lines from patients with PROM1-related retinopathies exhibiting diverse phenotypes

    Stem Cell Research and Therapy, Vol. 15, Núm. 1

  2. Evaluation of the neuroprotective efficacy of the gramine derivative ITH12657 against NMDA-induced excitotoxicity in the rat retina

    Frontiers in Neuroanatomy, Vol. 18

2023

  1. Ala®sil chemical characterization and toxicity evaluation: an example of the need for the Medical Device Regulation 2017/745

    Frontiers in Pharmacology, Vol. 14

  2. Does PLEX® Elite 9000 OCT Identify and Characterize Most Posterior Pole Lesions in Highly Myopic Patients?

    Journal of Clinical Medicine, Vol. 12, Núm. 5

  3. Safety, biocompatibility, and potential functionality of a new accommodative intraocular lens: An experimental study in rabbits

    Heliyon, Vol. 9, Núm. 9

2022

  1. Factors influencing mesenchymal stromal cells in in vitro cellular models to study retinal pigment epithelial cell rescue

    Human Cell, Vol. 35, Núm. 4, pp. 1005-1015

  2. Programmed Cell Death and Autophagy in an in vitro Model of Spontaneous Neuroretinal Degeneration

    Frontiers in Neuroanatomy, Vol. 16

  3. Retinal Neuroprotective Effect of Mesenchymal Stem Cells Secretome Through Modulation of Oxidative Stress, Autophagy, and Programmed Cell Death

    Investigative ophthalmology & visual science, Vol. 63, Núm. 4, pp. 27

2021

  1. Dexamethasone plga microspheres for sub-tenon administration: Influence of sterilization and tolerance studies

    Pharmaceutics, Vol. 13, Núm. 2, pp. 1-21

  2. Ex Vivo Model of Spontaneous Neuroretinal Degeneration for Evaluating Stem Cells’ Paracrine Properties

    Methods in Molecular Biology (Humana Press Inc.), pp. 125-137

  3. Ex-Vivo Method to Quantifiably Evaluate the Staining Effectiveness of Anterior Lens Capsule Dyes

    Translational vision science & technology, Vol. 10, Núm. 14, pp. 17

  4. Intraocular toxicity caused by MEROCTANE perfluorocarbon liquid

    Scientific Reports, Vol. 11, Núm. 1

  5. Neuroprotective therapy for retinal neurodegenerative diseases by stem cell secretome

    Neural Regeneration Research, Vol. 16, Núm. 1, pp. 117-118

2020

  1. Chemical compounds causing severe acute toxicity in heavy liquids used for intraocular surgery

    Regulatory Toxicology and Pharmacology, Vol. 110

  2. Human Mesenchymal Stem Cell Secretome Exhibits a Neuroprotective Effect over In Vitro Retinal Photoreceptor Degeneration

    Molecular Therapy - Methods and Clinical Development, Vol. 17, pp. 1155-1166

  3. Intravitreal stem cell paracrine properties as a potential neuroprotective therapy for retinal photoreceptor neurodegenerative diseases

    Neural Regeneration Research, Vol. 15, Núm. 9, pp. 1631-1638

  4. Mesenchymal Stem Cell Secretome Enhancement by Nicotinamide and Vasoactive Intestinal Peptide: A New Therapeutic Approach for Retinal Degenerative Diseases

    Stem Cells International, Vol. 2020

2019

  1. Acute retinal toxicity associated with a mixture of perfluorooctane and perfluorohexyloctane: Failure of another indirect cytotoxicity analysis

    British Journal of Ophthalmology, Vol. 103, Núm. 1, pp. 49-54

  2. Chemical considerations regarding the H-value methodology and its relation with toxicity determination

    Investigative Ophthalmology and Visual Science

  3. Mesenchymal stem cells provide paracrine neuroprotective resources that delay degeneration of co-cultured organotypic neuroretinal cultures

    Experimental Eye Research, Vol. 185